Links to the data used in the analysis, along with references, are provided in the main text of the manuscript.

Introduction {#sec001}
============

Ever since large-scale gene expression measurements have been possible, clustering---of both genes and samples---has played a major role in their analysis \[[@pgen.1006599.ref001]--[@pgen.1006599.ref003]\]. For example, clustering of genes can identify genes that are working together or are co-regulated, and clustering of samples is useful for quality control as well as identifying biologically-distinct subgroups. A wide range of clustering methods have therefore been employed in this context, including distance-based hierarchical clustering, *k*-means clustering, and self-organizing maps (SOMs); see for example \[[@pgen.1006599.ref004], [@pgen.1006599.ref005]\] for reviews.

Here we focus on cluster analysis of samples, rather than clustering of genes (although our methods do highlight sets of genes that distinguish each cluster). Traditional clustering methods for this problem attempt to partition samples into distinct groups that show "similar" expression patterns. While partitioning samples in this way has intuitive appeal, it seems likely that the structure of a typical gene expression data set will be too complex to be fully captured by such a partitioning. Motivated by this, here we analyse expression data using grade of membership (GoM) models \[[@pgen.1006599.ref006]\], which generalize clustering models to allow each sample to have partial membership in multiple clusters. That is, they allow that each sample has a proportion, or "grade" of membership in each cluster. Such models are widely used in population genetics to model admixture, where individuals can have ancestry from multiple populations \[[@pgen.1006599.ref007]\], and in document clustering \[[@pgen.1006599.ref008], [@pgen.1006599.ref009]\] where each document can have membership in multiple topics. In these fields GoM models are often known as "admixture models", and "topic models" or "Latent Dirichlet Allocation" \[[@pgen.1006599.ref008]\]. GoM models have also recently been applied to detect mutation signatures in cancer samples \[[@pgen.1006599.ref010]\].

Although we are not the first to apply GoM-like models to gene expression data, previous applications have been primarily motivated by a specific goal, "cell type deconvolution", which involves using cell-type-specific expression profiles of marker genes to estimate the proportions of different cell types in a mixture \[[@pgen.1006599.ref011]--[@pgen.1006599.ref013]\]. Specifically, the GoM model we use here is analogous to---although different in detail from---blind deconvolution approaches \[[@pgen.1006599.ref014]--[@pgen.1006599.ref016]\] which estimate cell type proportions and cell type signatures jointly (see also \[[@pgen.1006599.ref017], [@pgen.1006599.ref018]\] for semi-supervised approaches). Our goal here is to demonstrate that GoM models can be useful much more broadly for understanding structure in RNA-seq data---not only to deconvolve mixtures of cell types. For example, in our analysis of human tissue samples from the GTEX project below, the GoM model usefully captures biological heterogeneity among samples even though the inferred grades of membership are unlikely to correspond precisely to proportions of specific cell types. And in our analyses of single-cell expression data the GoM model highlights interesting structure, even though interpreting the grades of membership as "proportions of cell types" is clearly inappropriate because each sample is a single cell! Here we are exploiting the GoM as a flexible extension of traditional cluster models, which can capture "continuous" variation among cells as well as the more "discrete" variation captured by cluster models. Indeed, the extent to which variation among cells can be described in terms of discrete clusters versus more continuous populations is a fundamental question that, when combined with appropriate single-cell RNA-seq data, the GoM models used here may ultimately help address.

Methods overview {#sec002}
----------------

We assume that the RNA-seq data on *N* samples has been summarized by a table of counts *C*~*N*×*G*~ = (*c*~*ng*~), where *c*~*ng*~ is the number of reads from sample *n* mapped to gene *g* (or other unit, such as transcript or exon) \[[@pgen.1006599.ref019]\]. The GoM model is a generalization of a cluster model, which allows that each sample has some proportion ("grade") of membership, in each cluster. For RNA-seq data this corresponds to assuming that each sample *n* has some proportion of its reads, *q*~*nk*~ coming from cluster *k*. In addition, each cluster *k* is characterized by a probability vector, *θ*~*k*⋅~, whose *g*th element represents the relative expression of gene *g* in cluster *k*. The GoM model is then $$\left( {c_{n1},c_{n2},\cdots,c_{nG}} \right) \sim \text{Multinomial}\left( {c_{n +},p_{n1},p_{n2},\cdots,p_{nG}} \right),$$ where $$p_{ng}\  ≔ \ \sum\limits_{k = 1}^{K}q_{nk}\theta_{kg}.$$ The number of clusters *K* is set by the analyst, and it can be helpful to explore multiple values of *K* (see [Discussion](#sec009){ref-type="sec"}).

To fit this model to RNA-seq data, we exploit the fact that this GoM model is commonly used for document clustering \[[@pgen.1006599.ref008]\]. This is because, just as RNA-seq samples can be summarized by counts of reads mapping to each possible gene in the genome, document data can be summarized by counts of each possible word in a dictionary. Recognizing this allows existing methods and software for document clustering to be applied directly to RNA-seq data. Here we use the R package `maptpx` \[[@pgen.1006599.ref020]\] to fit the GoM model.

Fitting the GoM model results in estimated membership proportions *q* for each sample, and estimated expression values *θ* for each cluster. We visualize the membership proportions for each sample using a "Structure plot" \[[@pgen.1006599.ref021]\], which is named for its widespread use in visualizing the results of the *Structure* software \[[@pgen.1006599.ref007]\] in population genetics. The Structure plot represents the estimated membership proportions of each sample as a stacked barchart, with bars of different colors representing different clusters. Consequently, samples that have similar membership proportions have similar amounts of each color. See [Fig 1](#pgen.1006599.g001){ref-type="fig"} for example.

![GTEx tissues Structure plot.\
(a): Structure plot of estimated membership proportions for GoM model with K = 20 clusters fit to 8, 555 tissue samples from 53 tissues in GTEx data. Each horizontal bar shows the cluster membership proportions for a single sample, ordered so that samples from the same tissue are adjacent to one another. Within each tissue, the samples are sorted by the proportional representation of the underlying clusters. (b): Structure plot of estimated membership proportions for K = 4 clusters fit to only the brain tissue samples. This analysis highlights finer-scale structure among the brain samples that is missed by the global analysis in (a).](pgen.1006599.g001){#pgen.1006599.g001}

To help biologically interpret the clusters inferred by the GoM model we also implemented methods to identify, for each cluster, which genes are most distinctively differentially expressed in that cluster; that is, which genes show the biggest difference in expression compared with the other most similar cluster (see [Methods](#sec010){ref-type="sec"}). Functions for fitting the GoM model, plotting the structure plots, and identifying the distinctive ("driving") genes in each cluster, are included in our R package `CountClust` \[[@pgen.1006599.ref022]\] available through Bioconductor \[[@pgen.1006599.ref023]\].

Results {#sec003}
=======

Bulk RNA-seq data of human tissue samples {#sec004}
-----------------------------------------

We begin by illustrating the GoM model on bulk RNA expression measurements from the GTEx project (V6 dbGaP accession phs000424.v6.p1, release date: Oct 19, 2015, <http://www.gtexportal.org/home/>). These data consist of per-gene read counts from RNA-seq performed on 8,555 samples collected from 450 human donors across 53 tissues, lymphoblastoid cell lines, and transformed fibroblast cell-lines. We analyzed 16,069 genes that satisfied filters (e.g. exceeding certain minimum expression levels) that were used during eQTL analyses by the GTEx project (gene list available in <http://stephenslab.github.io/count-clustering/project/utilities/gene_names_all_gtex.txt>).

We fit the GoM model to these data, with number of clusters *K* = 5, 10, 15, 20. For each *K* we ran the fitting algorithm three times and kept the result with the highest log-likelihood. As might be expected, increasing *K* highlights finer structure in the data, and for brevity we focus discussion on results for *K* = 20 ([Fig 1(a)](#pgen.1006599.g001){ref-type="fig"}), with results for other *K* shown in [S1 Fig](#pgen.1006599.s001){ref-type="supplementary-material"}. For comparison we also ran several other commonly-used methods for clustering and visualizing gene expression data: Principal Components Analysis (PCA), Multidimensional Scaling (MDS), *t*-Distributed Stochastic Neighbor Embedding (*t*-SNE) \[[@pgen.1006599.ref024], [@pgen.1006599.ref025]\], and hierarchical clustering ([Fig 2](#pgen.1006599.g002){ref-type="fig"}).

![Visualization of the same GTEx data as in [Fig 1](#pgen.1006599.g001){ref-type="fig"}.\
(a) across all tissues using standard and widely used approaches---Principal Component Analysis (PCA), Multi dimensional Scaling (MDS), t-SNE and hierarchical clustering. All the analysis are done on log CPM normalized expression data to remove library size effects. (a): Plot of PC1 vs PC2 on the log CPM expression data, (b): Plot of first two dimensions of the t-SNE plot, (c) Plot of first two dimensions of the Multi-Dimensional Scaling (MDS) plot. (d) Dendrogram for the hierarchical clustering of the GTEx tissue samples based on the log CPM expression data with average linkage and Euclidean distance.](pgen.1006599.g002){#pgen.1006599.g002}

These data present a challenge to visualization and clustering tools, because of both the relatively large number of samples and the complex structure created by the inclusion of many different tissues. Indeed, neither PCA nor MDS provide satisfactory summaries of the structure in these data ([Fig 2(a) and 2(b)](#pgen.1006599.g002){ref-type="fig"}): samples from quite different tissues are often super-imposed on one another in plots of PC1 vs PC2, and this issue is only partly alleviated by examining more PCs ([S2 Fig](#pgen.1006599.s002){ref-type="supplementary-material"}). The hierarchical clustering provides perhaps better separation of tissues ([Fig 2(d)](#pgen.1006599.g002){ref-type="fig"}), but producing a clear (static) visualization of the tree is difficult with this many samples. By comparison *t*-SNE ([Fig 2(b)](#pgen.1006599.g002){ref-type="fig"}) and the GoM model ([Fig 1(a)](#pgen.1006599.g001){ref-type="fig"}) both show a much clearer visual separation of samples by tissue, although they achieve this in very different ways. The *t*-SNE representation produces a two-dimensional plot with 20--25 visually-distinct clusters. In contrast, the GoM highlights similarity among samples by assigning them similar membership proportions, resulting in groups of similarly-colored bars in the structure plot. Some tissues are represented by essentially a single cluster/color (e.g. Pancreas, Liver), whereas other tissues are represented as a mixture of multiple clusters (e.g. Thyroid, Spleen). Furthermore, the GoM results highlight biological similarity among some tissues by assigning similar membership proportions to samples from those tissues. For example, samples from several different parts of the brain often have similar memberships, as do the arteries (aorta, tibial and coronary) and skin samples (sun-exposed and un-exposed).

Although it is not surprising that samples cluster by tissue, other results could have occurred. For example, samples could have clustered according to technical variables, such as sequencing batch \[[@pgen.1006599.ref026]\] or sample collection center. While our results do not exclude the possibility that technical variables could have influenced these data, the *t*-SNE and GoM results clearly demonstrate that tissue of origin is the primary source of heterogeneity, and provide a useful initial assurance of data quality.

While in these data both the GoM model and *t*-SNE highlight the primary structure due to tissue of origin, the GoM results have at least two advantages over *t*-SNE. First, the GoM model provides an explicit, quantitative, estimate of the mean expression of each gene in each cluster, making it straightforward to assess which genes and processes drive differences among clusters; see [Table 1](#pgen.1006599.t001){ref-type="table"} (and also [S1 Table](#pgen.1006599.s013){ref-type="supplementary-material"}). Reassuringly, many results align with known biology. For example, the purple cluster (cluster 18), which distinguishes Pancreas from other tissues, is enriched for genes responsible for digestion and proteolysis, (e.g. *PRSS1*, *CPA1*, *PNLIP*). Similarly the yellow cluster (cluster 12), which primarily distinguishes Cell EBV Lymphocytes from other tissues, is enriched with genes responsible for immune responses (e.g. *IGHM*, *IGHG1*) and the pink cluster (cluster 19) which mainly appears in Whole Blood, is enriched with genes related hemoglobin complex and oxygen transport (e.g. *HBB*, *HBA1*, *HBA2*). Further, Keratin-related genes characterize the skin cluster (cluster 6, light denim), Myosin-related genes characterize the muscle skeletal cluster (cluster 7, orange), etc. These biological annotations are particularly helpful for understanding instances where a cluster appears in multiple tissues. For example, the top genes in the salmon cluster (cluster 4), which is common to the Gastroesophageal Junction, Esophagus Muscularis and Colon Sigmoid, are related to smooth muscle. And the top genes in the red cluster, highlighted above as common to Breast Mammary tissue, Adipose Subcutaneous and Adipose Visceral, are all related to adipocytes and/or fatty acid synthesis.

10.1371/journal.pgen.1006599.t001

###### Cluster Annotations GTEx V6 data (with GO annotations).

![](pgen.1006599.t001){#pgen.1006599.t001g}

  Cluster            Top 5 Driving Genes                     Top significant GO terms (function)\[q-value\]
  ------------------ --------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Royal purple   *NEAT1, IGFBP5, CCLN2, SRSF5, PNISR*    GO:0005654 (nucleoplasm)\[2e-10\], GO:0044822 (poly-A RNA binding)\[3e-09\], GO:0044428 (nuclear part)\[1e-09\], GO:0043233 (organelle lumen)\[2e-08\]
  2\. Light purple   *SNAP25, FBXL16, NCDN, SNCB, SLC17A7*   GO:0097458 (neuron part)\[2e-25\], GO:0007268 (synaptic transmission)\[9e-18\], GO:0030182 (neuron differentiation)\[2e-14\], GO:0022008 (neurogenesis)\[1e-13\], GO:0007267 (cell-cell signaling)\[3e-13\]
  3\. Red            *FABP4, PLIN1, FASN, GPX3, LIPE*        GO:0044255 (cellular lipid metabolism)\[1e-09\], GO:0006629 (lipid metabolism)\[1e-09\], GO:0006639 (acylglycerol metabolism)\[3e-08\], GO:0045765 (angiogenesis regulation)\[4e-08\]
  4\. Salmon         *ACTG2, MYH11, SYNM, MYLK, CSRP1*       GO:0043292 (contractile fiber)\[3e-13\], GO:0006936 (muscle contraction)\[5e-12\], GO:0030016 (myofibril)\[5e-12\], GO:0015629 (actin cytoskeleton)\[2e-12\], GO:0005925 (focal adhesion)\[6e-11\]
  5\. Denim          *RGS5, MGP, AEBP1, IGFBP7, MFGE8*       GO:0005578 (proteinaceous extracellular matrix)\[4e-20\], GO:0030198 (extracellular matrix)\[2e-18\], GO:0007155 (cell adhesion)\[4e-14\], GO:0001568 (blood vessel development)\[4e-13\]
  6\. Light denim    *KRT10, KRT1, KRT2, LOR, KRT14*         GO:0008544 (epidermis development)\[3e-12\], GO:0043588 (skin development)\[5e-10\], GO:0042303 (molting cycle)\[8e-06\], GO:0042633 (hair cycle)\[7e-06\], GO:0048513 (organ development)\[6e-05\]
  7\. Orange         *NEB, MYH1, MYH2, MYBPC1, ACTA1*        GO:0043292 (contractile fiber)\[6e-52\], GO:0030016 (myofibril)\[1e-51\], GO:0030017 (sarcomere)\[5e-40\], GO:0003012 (muscle system process)\[2e-25\], GO:0015629 (actin cytoskeleton)\[1e-25\]
  8\. Light orange   *FN1, COL1A1, COL1A2, COL3A1, COL6A3*   GO:0030198 (extracellular matrix)\[6e-29\], GO:0043062 (extracellular structure)\[4e-29\], GO:0032963 (collagen metabolism)\[3e-16\], GO:0030199 (collagen fibril organization)\[1e-14\], GO:0030574 (collagen catabolism)\[1e-14\]
  9\. Green          *MBP, GFAP, MTURN, HIPK2, CARNS1*       GO:0043209 (myelin sheath)\[4e-07\], GO:0007399 (nervous system development)\[4e-05\], GO:0008366 (axon ensheathment)\[9e-05\], GO:0044430 (cytoskeletal part)\[1e-04\], GO:0005874 (microtubule)\[3e-04\]
  10\. Light green   *CYP17A1, CYP11B1, PIGR, GKN1, STAR*    GO:0006694 (steroid biosynthesis)\[2e-13\], GO:0008202 (steroid metabolism)\[1e-12\], GO:0016125 (sterol metabolism)\[1e-11\], GO:0042446 (hormone biosynthesis)\[1e-10\], GO:0008207 (C21-steroid hormone metabolism)\[3e-10\]
  11\. Turquoise     *MPZ, APOD, PMP22, PRX, NGFR*           GO:0007272 (ensheathment of neurons)\[4e-07\], GO:0008366 (axon ensheathment)\[7e-07\], GO:0042552 (myelination)\[7e-06\], GO:0048856 (anatomical structure development)\[1e-06\], GO:0005578 (proteinaceous extracellular matrix)\[1e-06\]
  12\. Yellow        *IGHM, IGHG1, IGHG2, IGHG4, CD74*       GO:0006955 (immune response)\[1e-18\], GO:0002252 (immune effector process)\[7e-18\], GO:0003823 (antigen binding)\[1e-15\], GO:0019724 (B-cell mediated immunity)\[5e-13\], GO:0002684 (positive regulation immune system)\[6e-13\]
  13\. Sky blue      *TG, PRL, GH1, PRM2, PRM1*              GO:0019953 (sexual reproduction)\[8e-10\], GO:0048232 (male gamete generation)\[2e-08\], GO:0035686 (sperm fibrous sheath)\[4e-06\], GO:0005179 (hormone activity)\[6e-05\], GO:0042403 (thyroid hormone metabolism)\[2e-04\]
  14\. Light pink    *NPPA, MYH6, TNNT2, ACTC1, MYBPC3*      GO:0045333 (cellular respiration)\[2e-34\], GO:0022904 (respiratory electron transport)\[8e-33\], GO:0015980 (energy derivation by oxidation of organic compounds)\[4e-30\], GO:0031966 (mitochondrial membrane)\[5e-26\]
  15\. Light gray    *KRT13, KRT4, MUC7, CRNN, KRT6A*        GO:0070062 (extracellular exosome)\[2e-23\], GO:0043230 (extracellular organelle)\[3e-23\], GO:0031982 (vesicle)\[3e-20\], GO:0008544 (epidermis development)\[2e-18\], GO:0043588 (skin development)\[1e-13\]
  16\. Gray          *SFTPBβ, SFTPA1, SFTPA2, SFTPC, A2M*    GO:0001525 (angiogenesis)\[5e-08\], GO:0001944 (vasculature development)\[2e-07\], GO:0048514 (blood vessel morphogenesis)\[2e-07\], GO:0040012 (locomotion regulation)\[4e-06\], GO:2000145 (cell motility)\[1e-05\]
  17\. Brown         *CSF3R, MMP25, IL1R2, SELL, VNN2*       GO:0006955 (immune response)\[8e-22\], GO:0006952 (defense response)\[9e-16\], GO:0071944 (cell periphery)\[7e-15\], GO:0005886 (plasma membrane)\[7e-15\], GO:0050776 (regulation of immune response)\[2e-12\]
  18\. Purple        *PRSS1, CPA1, PNLIP, CELA3A, GP2*       GO:0007586 (digestion)\[3e-14\], GO:0004252 (serine-type endopeptidase activity)\[4e-08\], GO:0006508 (proteolysis)\[6e-06\], GO:0016787 (hydrolase activity)\[6e-05\], GO:0044241 (lipid digestion)\[1e-04\]
  19\. Pink          *HBB, HBA2, HBA1, FKBP8, HBD*           GO:0005833 (hemoglobin complex)\[1e-13\], GO:0015669 (gas transport)\[4e-11\], GO:0020037 (heme binding)\[3e-07\], GO:0031720 (haptoglobin binding)\[3e-06\], GO:0006950 (response to stress)\[6e-04\]
  20\. Dark gray     *ALB, HP, FGB, FGA, ORM1*               GO:0072562 (blood microparticle)\[1e-27\], GO:0043230 (extracellular organelle)\[1e-24\], GO:0044710 (single organism metabolism)\[7e-20\], GO:0019752 (carboxylic acid metabolism)\[1e-18\], GO:0034364 (high density lipoprotein)\[3e-16\]

A second advantage of the GoM model is that, because it allows partial membership in each cluster, it is better able to highlight partial similarities among distinct tissues. For example, in [Fig 1(a)](#pgen.1006599.g001){ref-type="fig"} the sky blue cluster (cluster 13), appears in testis, pituitary, and thyroid, reflecting shared hormonal-related processes. At the same time, these tissues are distinguished from one another both by their degree of membership in this cluster (testis samples have consistently stronger membership; thyroid samples consistently weaker), and by membership in other clusters. For example, pituitary samples, but not testis or thyroid samples, have membership in the light purple cluster (cluster 2) which is driven by genes related to neurons and synapsis. In the *t*-SNE results these three tissues simply cluster separately into visually distinct groups, with no indication that their expression profiles have something in common ([Fig 2(b)](#pgen.1006599.g002){ref-type="fig"}). Thus, although we find the *t*-SNE results visually attractive, this 2-dimensional projection contains less information than the Structure plot from the GoM ([Fig 1(a)](#pgen.1006599.g001){ref-type="fig"}), which uses color to represent the samples in a 20-dimensional space.

In addition to these qualitative comparisons with other methods, we also used the GTEx data to quantitatively compare the accuracy of the GoM model with hierarchical clustering. Specifically, for each pair of tissues in the GTEx data we assessed whether or not each method correctly partitioned samples into the two tissue groups; see [Methods](#sec010){ref-type="sec"}. (Other methods do not provide an explicit clustering of the samples---only a visual representation---and so are not included in these comparisons.) The GoM model was more accurate in this test, succeeding in 88% of comparisons, compared with 79% for hierarchical clustering ([S3(a) vs S3(c) Fig](#pgen.1006599.s003){ref-type="supplementary-material"}).

Sub-analysis of brain tissues {#sec005}
-----------------------------

Although the analysis of all tissues is useful for assessing global structure, it may miss finer-scale structure within tissues or among similar tissues. For example, here the GoM model applied to all tissues effectively allocated only three clusters to all brain tissues (clusters 1,2 and 9 in [Fig 1(a)](#pgen.1006599.g001){ref-type="fig"}), and we suspected that additional substructure might be uncovered by analyzing the brain samples separately and using more clusters. [Fig 1(b)](#pgen.1006599.g001){ref-type="fig"} shows the Structure plot for *K* = 6 on only the Brain samples. The results highlight much finer-scale structure compared with the global analysis; see [Table 2](#pgen.1006599.t002){ref-type="table"}. Brain Cerebellum and Cerebellar hemisphere are essentially assigned to a separate cluster (lime green), which is enriched with genes related to cell periphery and communication (e.g. *PKD1*, *CBLN3*) as well as genes expressed largely in neuronal cells and playing a role in neuron differentiation (e.g. *CHGB*). The spinal cord samples also show consistently strong membership in a single cluster (yellow-orange), the top defining gene for the cluster being *MBP* which is involved in myelination of nerves in the nervous system \[[@pgen.1006599.ref027]\]. Another driving gene, *GFAP*, participates in system development by acting as a marker to distinguish astrocytes during development \[[@pgen.1006599.ref028]\].

10.1371/journal.pgen.1006599.t002

###### Cluster Annotations for GTEx V6 Brain data.

![](pgen.1006599.t002){#pgen.1006599.t002g}

  Cluster             Top 5 Driving Genes                      Top significant GO terms
  ------------------- ---------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Royal blue      *CLU, OXT, GLUL, NDRG2, CST3*            GO:0043230 (extracellular organelle)\[5e-11\], GO:1903561 (extracellular vesicle)\[6e-11\], GO:0070062 (extracellular exosome)\[2e-09\], GO:0006950 (response to stress)\[3e-10\], GO:0031988 (membrane bound vesicle)\[1e-10\]
  2\. Turquoise       *ENC1, NCALD, YWHAH, KIF5A, NPTXR*       GO:0097458 (neuron part)\[3e-11\], GO:0008092 (cytoskeletal protein binding)\[7e-11\], GO:0031175 (neuron projection development)\[7e-09\], GO:0030182 (neuron differentiation)\[4e-08\], GO:0007268 (synaptic transmission)\[1e-08\]
  3\. Lime green      *PKD1, CBLN3, CHGB, COL27A1, ABLIM1*     GO:0005089 (Rho guanyl-nucleotide exchange factor activity)\[1e-03\], GO:0016604 (nuclear body)\[0.002\], GO:0022008 (neurogenesis)\[0.02\], GO:0035239 (tube morphogenesis)\[0.08\], GO:0007269 (neurotransmitter secretion)\[0.10\]
  4\. Red             *PPP1R1B, RGS14, NCDN, PDE1B, RAP1GAP*   GO:0065009 (regulation of molecular function)\[2e-06\], GO:0036477 (somatodendritic compartment)\[6e-05\], GO:0007268 (synaptic transmission)\[1e-03\], GO:0023051 (signaling regulation)\[2e-03\], GO:0010646 (cell communication regulation)\[1e-03\]
  5\. Yellow orange   *MBP, GFAP, TF, MTURN, SCD*              GO:0043209 (myelin sheath)\[2e-09\], GO:0007399 (nervous system development)\[1e-04\], GO:0005737 (cytoplasm)\[1e-04\], GO:0048471 (perinuclear region of cytoplasm)\[5e-04\], GO:0007272 (ensheathment of neurons)\[1e-02\]
  6\. Yellow          *IQGAP1, A2M, C3, MYH7, TG*              GO:0072562 (blood microparticle)\[1e-10\], GO:0044449 (contractile fiber part)\[1e-10\], GO:0043230 (extracellular organelle)\[7e-10\], GO:0030017 (sarcomere)\[1e-08\], GO:0072376 (protein activation cascade)\[1e-08\]

The remaining samples all show membership in multiple clusters. Samples from the putamen, caudate and nucleus accumbens show similar profiles, and are distinguished by strong membership in a cluster (cluster 4, bright red) whose top driving gene is *PPP1R1B*, a target for dopamine. And cortex samples are distinguished from others by stronger membership in a cluster (cluster 2, turquoise in [Fig 1(b)](#pgen.1006599.g001){ref-type="fig"}) whose distinctive genes include *ENC1*, which interacts with actin and contributes to the organisation of the cytoskeleton during the specification of neural fate \[[@pgen.1006599.ref029]\].

In comparison, applying PCA, MDS, hierarchical clustering and *t*-SNE to these brain samples reveals less of this finer-scale structure ([S4 Fig](#pgen.1006599.s004){ref-type="supplementary-material"}). Both PCA and MDS effectively cluster the samples into two groups---those related to the cerebellum vs everything else. Hierarchical clustering also separates out the cerebellum-related tissues from the others, but again the format seems ill-suited to static visualization of more than one thousand samples. For reasons that we do not understand *t*-SNE performs poorly for these data: many samples are allocated to essentially identical locations, and so overplotting obscures them.

Single-cell RNA-seq data {#sec006}
------------------------

Recently RNA-sequencing has become viable for single cells \[[@pgen.1006599.ref030]\], and this technology has the promise to revolutionize understanding of intra-cellular variation in expression, and regulation more generally \[[@pgen.1006599.ref031]\]. Although it is traditional to describe and categorize cells in terms of distinct cell-types, the actual architecture of cell heterogeneity may be more complex, and in some cases perhaps better captured by the more "continuous" GoM model. In this section we illustrate the potential for the GoM model to be applied to single cell data.

To be applicable to single-cell RNA-seq data, methods must be able to deal with lower sequencing depth than in bulk RNA experiments: single-cell RNA-seq data typically involve substantially lower effective sequencing depth compared with bulk experiments, due to the relatively small number of molecules available to sequence in a single cell. Therefore, as a first step towards demonstrating its potential for single cell analysis, we checked robustness of the GoM model to sequencing depth. Specifically, we repeated the analyses above after thinning the GTEx data by a factor of 100 and 10,000 to mimic the lower sequencing depth of a typical single cell experiment. For the thinned GTEx data the Structure plot for *K* = 20 preserves most of the major features of the original analysis on unthinned data ([S5 Fig](#pgen.1006599.s005){ref-type="supplementary-material"}). For the accuracy comparisons with hierarchical clustering, both methods suffer reduced accuracy in thinned data, but the GoM model remains superior ([S6 Fig](#pgen.1006599.s006){ref-type="supplementary-material"}). For example, when thinning by a factor of 10,000, the success rate in separating pairs of tissues is 0.32 for the GoM model vs 0.10 for hierarchical clustering.

Having established its robustness to sequencing depth, we now illustrate the GoM model on two single cell RNA-seq datasets: data on mouse spleen from Jaitin *et al* \[[@pgen.1006599.ref032]\] and data on mouse preimplantation embryos from Deng *et al* \[[@pgen.1006599.ref033]\].

### Mouse spleen data from Jaitin et al, 2014 {#sec007}

Jaitin *et al* sequenced over 4,000 single cells from mouse spleen. Here we analyze 1,041 of these cells that were categorized as *CD*11*c*+ in the *sorting markers* column of their data (<http://compgenomics.weizmann.ac.il/tanay/?page_id=519>), and which had total number of reads mapping to non-ERCC genes greater than 600. Our hope was that applying the GoM model to these data would identify, and perhaps refine, the cluster structure evident in \[[@pgen.1006599.ref032]\] (their [Fig 2A and 2B](#pgen.1006599.g002){ref-type="fig"}). However, the GoM model yielded rather different results ([Fig 3](#pgen.1006599.g003){ref-type="fig"}), where most cells were assigned to have membership in several clusters. Further, the cluster membership vectors showed systematic differences among amplification batches (which in these data is also strongly correlated with sequencing batch). For example, cells in batch 1 are characterized by strong membership in the orange cluster (cluster 5) while those in batch 4 are characterized by strong membership in both the blue and yellow clusters (2 and 6). Some adjacent batches show similar patterns---for example batches 28 and 29 have a similar visual "palette", as do batches 32--45. And, more generally, these later batches are collectively more similar to one another than they are to the earlier batches (0--4).

![Structure plot of estimated membership proportions for GoM model with K = 7 clusters fit to 1,041 single cells from \[[@pgen.1006599.ref033]\].\
The samples (cells) are ordered so that samples from the same amplification batch are adjacent and within each batch, the samples are sorted by the proportional representation of the underlying clusters. In this analysis the samples do not appear to form clearly-defined clusters, with each sample being allocated membership in several "clusters". Membership proportions are correlated with batch, and some groups of batches (e.g. 28--29; 32--45) show similar palettes. These results suggest that batch effects are likely influencing the inferred structure in these data.](pgen.1006599.g003){#pgen.1006599.g003}

The fact that batch effects are detectable in these data is not particularly surprising: there is a growing recognition of the importance of batch effects in high-throughput data generally \[[@pgen.1006599.ref034], [@pgen.1006599.ref035]\] and in single cell data specifically \[[@pgen.1006599.ref026], [@pgen.1006599.ref036]\]. And indeed, both clustering methods and the GoM model can be viewed as dimension reduction methods, and such methods can be helpful in controlling for batch effects \[[@pgen.1006599.ref037], [@pgen.1006599.ref038]\]. However, why these batch effects are not evident in Fig 2A and 2B of \[[@pgen.1006599.ref032]\] is unclear.

### Mouse preimplantation embryo data from Deng et al, 2014 {#sec008}

Deng *et al* collected single-cell expression data of mouse preimplantation embryos from the zygote to blastocyst stage \[[@pgen.1006599.ref033]\], with cells from four different embryos sequenced at each stage. The original analysis \[[@pgen.1006599.ref033]\] focuses on trends of allele-specific expression in early embryonic development. Here we use the GoM model to assess the primary structure in these data without regard to allele-specific effects (i.e. combining counts of the two alleles). Visual inspection of the Principal Components Analysis in \[[@pgen.1006599.ref033]\] suggested perhaps 6--7 clusters, and we focus here on results with *K* = 6.

The results from the GoM model ([Fig 4](#pgen.1006599.g004){ref-type="fig"}) clearly highlight changes in expression profiles that occur through early embryonic development stages, and enrichment analysis of the driving genes in each cluster ([Table 3](#pgen.1006599.t003){ref-type="table"}, [S4 Table](#pgen.1006599.s016){ref-type="supplementary-material"}) indicate that many of these expression changes reflect important biological processes during embryonic preimplantation development.

![Structure plot of estimated membership proportions for GoM model with K = 6 clusters fit to 259 single cells from \[[@pgen.1006599.ref033]\].\
The cells are ordered by their preimplantation development phase (and within each phase, sorted by the proportional representation of the clusters). While the very earliest developmental phases (zygote and early 2-cell) are essentially assigned to a single cluster, others have membership in multiple clusters. Each cluster is annotated by the genes that are most distinctively expressed in that cluster, and by the gene ontology categories for which these distinctive genes are most enriched (see [Table 1](#pgen.1006599.t001){ref-type="table"} for more extensive annotation results). See text for discussion of biological processes driving these results.](pgen.1006599.g004){#pgen.1006599.g004}

10.1371/journal.pgen.1006599.t003

###### Cluster Annotations for Deng et al (2014) data.

![](pgen.1006599.t003){#pgen.1006599.t003g}

  Cluster       Top 10 Driving Genes                                                                                               Top significant GO terms
  ------------- ------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Blue      *Bcl2l10*, *E330034G19Rik*, *Tcl1*, *LOC100502936*, *Oas1d*, *AU022751*, *Spin1*, *Khdc1b*, *D6Ertd527e*, *Btg4*   GO:0007276 (gamete generation)\[7e-06\], GO:0032504 (multicellular organism reproduction)\[3e-06\], GO:0044702 (single organism reproduction)\[2e-05\], GO:0048477 (oogenesis)\[5e-04\], GO:0048599 (oocyte development)\[1e-03\], GO:0009994 (oocyte differentiation)\[1e-03\]
  2\. Magenta   *Obox3*, *Zfp352*, *Gm8300*, *Usp17l5*, *BB287469*, *Rfpl4b*, *Gm2022*, *Gm5662*, *Gm11544*, *Gm4850*              GO:0016604 (nuclear body)\[1e-04\], GO:0005814 (centriole)\[4e-03\], GO:0044450 (microtubule organizing center part) \[8e-03\]
  3\. Yellow    *Rtn2*, *Ebna1bp2*, *Zfp259*, *Nasp*, *Cenpe*, *Rnf216*, *Ctsl*, *Tor1b*, *Ankrd10*, *Lamp2*                       GO:0044428 (nuclear part)\[1e-08\], GO:0031981 (nuclear lumen)\[3e-08\], GO:0070013 (intracellular organelle lumen)\[9e-08\], GO:0005730 (nucleolus)\[5e-07\], GO:0005654 (nucleoplasm)\[4e-05\], GO:0003723 (RNA binding)\[1e-04\]
  4\. Green     *Timd2*, *Isyna1*, *Alppl2*, *Prame15*, *Fbxo15*, *Tceb1*, *Gpd1l*, *Pemt*, *Hsp90aa1*, *Hsp90ab1*                 GO:0005829 (cytosol)\[4e-10\], GO:0044444 (cytoplasmic part)\[2e-05\], GO:1901575 (organic substance catabolic process)\[9e-04\], GO:0000151 (ubiquitin ligase com- plex)\[1e-04\], GO:0009056 (catabolic process)\[1e-03\], GO:0044265 (cellular macromolecule catabolic process)\[1e-03\], GO:0051082 (unfolded protein binding)\[9e-04\]
  5\. Purple    *Upp1*, *Tdgf1*, *Aqp8*, *Fabp5*, *Tat*, *Pdgfra*, *Pyy*, *Prdx1*, *Col4a1*, *Spp1*                                GO:0044710 (single-organism metabolic process) \[1e-05\], GO:0006950 (response to stress) \[1e-05\], GO:0070062 (extracellular exosome)\[1e-05\], GO:0043230 (extracellular organelle)\[2e-05\], GO:1903561 (extracellular vesicle)\[1e-05\], GO:0006979 (response to oxidative stress)\[7e-04\], GO:0048514 (blood vessel morphogenesis)\[7e-04\], GO:0001944 (vasculature development)\[3e-03\]
  6\. Orange    *Actb*, *Krt18*, *Fabp3*, *Id2*, *Tspan8*, *Gm2a*, *Lgals1*, *Adh1*, *Lrp2*, *BC051665*                            GO:0065010 (extracellular membrane-bounded organelle), GO:0070062 (extracellular exosome)\[4e-23\], GO:0043230 (extracellular organelle)\[5e-23\], GO:1903561 (extracellular vesicle)\[3e-23\], GO:0031982 (vesicle)\[4e-18\], GO:0030036 (actin cytoskeleton and organization)\[4e-12\], GO:0032432 (actin filament bundle)\[2e-09\], GO:0005912 (adherens junction)\[2e-09\]

In more detail: Initially, at the zygote and early 2-cell stages, the embryos are represented by a single cluster (blue in [Fig 4](#pgen.1006599.g004){ref-type="fig"}) that is enriched with genes responsible for germ cell development (e.g., *Bcl2l10* \[[@pgen.1006599.ref039]\], *Spin1* \[[@pgen.1006599.ref040]\]). Moving through subsequent stages the grades of membership evolve to a mixture of blue and magenta clusters (mid 2-cell), a mixture of magenta and yellow clusters (late 2-cell) and a mixture of yellow and green (4-cell stage). The green cluster then becomes more prominent in the 8-cell and 16-cell stages, before dropping substantially in the early and mid-blastocyst stages. That is, we see a progression in the importance of different clusters through these stages, from the blue cluster, moving through magenta and yellow to green. Examining the genes distinguishing each cluster reveals that this progression (blue-magenta-yellow-green) reflects the changing relative importance of several fundamental biological processes. The magenta cluster is driven by genes responsible for the beginning of transcription of zygotic genes (e.g., *Zscan4c-f* show up in the list of top 100 driving genes: see <https://stephenslab.github.io/count-clustering/project/src/deng_cluster_annotations.html>), which takes place in the late 2-cell stage of early mouse embryonic development \[[@pgen.1006599.ref041]\]. The yellow cluster is enriched for genes responsible for heterochromation *Smarcc1* \[[@pgen.1006599.ref042]\] and chromosome stability *Cenpe* \[[@pgen.1006599.ref043]\] (see [S4 Table](#pgen.1006599.s016){ref-type="supplementary-material"}). And the green cluster is enriched for cytoskeletal genes (e.g., *Fbxo15*) and cytoplasm genes (e.g., *Tceb1*, *Hsp90ab1*), all of which are essential for compaction at the 8-cell stage and morula formation at the 16-cell stage.

Finally, during the blastocyst stages two new clusters (purple and orange in [Fig 4](#pgen.1006599.g004){ref-type="fig"}) dominate. The orange cluster is enriched with genes involved in the formation of trophectoderm (TE) (e.g., *Tspan8*, *Krt8*, *Id2* \[[@pgen.1006599.ref044]\]), while the purple cluster is enriched with genes responsible for the formation of inner cell mass (ICM) (e.g., *Pdgfra*, *Pyy* \[[@pgen.1006599.ref045]\]).

For comparison, results for PCA, MDS, *t*-SNE and hierarchical clustering are shown in [S7 Fig](#pgen.1006599.s007){ref-type="supplementary-material"}. All these methods show some clustering structure by pre-implantation stage; however only PCA and MDS seem to capture the developmental trajectory from zygote to blastocyst, exhibiting a "horse-shoe" pattern that is expected when similarities among samples approximately reflect an underlying latent ordering \[[@pgen.1006599.ref046], [@pgen.1006599.ref047]\]. And none of them provide any direct indication of the ICM vs TE structure in the blastocyst samples.

Although the GoM model results clearly highlight some of the key biological processes underlying embryonic preimplantation development, there are also some expected patterns that do not appear. Specifically, just prior to implantation the embryo consists of three different cell types, the trophectoderm (TE), the primitive endoderm (PE), and the epiblast (EPI) \[[@pgen.1006599.ref048]\], with the PE and EPI being formed from the ICM. Thus one might expect the late blastocyst cells to show a clear division into three distinct groups, and for some of the earlier blastocyst cells to show partial membership in one of these groups as they begin to differentiate towards these cell types. Indeed, the GoM model seems well suited to capture this process in principle. However, this is not the result we obtained in practice. In particular, although the two clusters identified by the GoM model in the blastocyst stages appear to correspond roughly to the TE and ICM, even the late blastocyst cells tend to show a gradient of memberships in both these clusters, rather than a clear division into distinct groups. Our results contrast with those from the single-cell mouse preimplantation data of \[[@pgen.1006599.ref044]\], measured by qPCR, where the late blastocyst cells showed a clear visual division into three groups using PCA (their [Fig 1](#pgen.1006599.g001){ref-type="fig"}).

To better understand the differences between our results for RNA-seq data from \[[@pgen.1006599.ref033]\] and the qPCR results from \[[@pgen.1006599.ref044]\] we applied the GoM model with *K* = 3 to a small subset of the RNA-seq data: the blastocyst cell data at the 48 genes assayed by \[[@pgen.1006599.ref044]\]. These genes were specifically chosen by them to help elucidate cell-fate decisions during early development of the mouse embryo. Still, the GoM model results ([S8 Fig](#pgen.1006599.s008){ref-type="supplementary-material"}) do not support a clear division of these data into three distinct groups (and neither do PCA or *t*-SNE; [S9 Fig](#pgen.1006599.s009){ref-type="supplementary-material"}). Rather, the GoM model highlights one cluster (Green in figure), whose membership proportions essentially reflect expression at the *Actb* gene, and two other clusters (Orange and Purple in figure) whose driving genes correspond to genes identified in \[[@pgen.1006599.ref044]\] as being distinctive to TE and EPI cell types respectively. The *Actb* gene is a "housekeeping gene", used by \[[@pgen.1006599.ref044]\] to normalize their qPCR data, and its prominence in the GoM results likely reflects its very high expression levels relative to other genes. However, excluding *Actb* from the analysis still does not lead to a clear separation into three groups ([S8 Fig](#pgen.1006599.s008){ref-type="supplementary-material"}). Thus, although there are clear commonalities in the structure of these RNA-seq and qPCR data sets, the structure of the single-cell RNA-seq data from \[[@pgen.1006599.ref033]\] is fundamentally more complex (or, perhaps, muddied), and consequently more difficult to interpret.

In addition to trends across development stages, the GoM results also highlight some embryo-level effects in the early stages ([Fig 4](#pgen.1006599.g004){ref-type="fig"}). Specifically, cells from the same embryo sometimes show greater similarity than cells from different embryos. For example, while all cells from the 16-cell stage have high memberships in the green cluster, cells from two of the embryos at this stage have memberships in both the purple and yellow clusters, while the other two embryos have memberships only in the yellow cluster.

The GoM results also highlight a few single cells as outliers. For example, a cell from a 16-cell embryo is represented by the blue cluster---a cluster that represents cells at the zygote and early 2-cell stage. Also, a cell from an 8-stage embryo has strong membership in the purple cluster---a cluster that represents cells from the blastocyst stage. This illustrates the potential for the GoM model to help in quality control: it would seem prudent to consider excluding these outlier cells from subsequent analyses of these data.

Discussion {#sec009}
==========

Our goal here is to highlight the potential for GoM models to elucidate structure in RNA-seq data from both single cell sequencing and bulk sequencing of pooled cells. We also provide tools to identify which genes are most distinctively expressed in each cluster, to aid interpretation of results. As our applications illustrate, the results can provide a richer summary of the structure in RNA-seq data than existing widely-used visualization methods such as PCA and hierarchical clustering. While it could be argued that the GoM model results sometimes raise more questions than they answer, this is exactly the point of an exploratory analysis tool: to highlight issues for investigation, identify anomalies, and generate hypotheses for future testing.

Our results from different methods also highlight another important point: different methods have different strengths and weaknesses, and can compliment one another as well as competing. For example, *t*-SNE seems to provide a much clearer indication of the cluster structure in the full GTEx data than does PCA, but does a poorer job of capturing the ordering of the developmental samples from mouse pre-implantation embryos. While we believe the GoM model often provides a richer summary of the sample structure, we would expect to use it in addition to *t*-SNE and PCA when performing exploratory analyses. (Indeed the methods can be used in combination: both PCA and *t*-SNE can be used to visualize the results of the GoM model, as an alternative or complement to the Structure plot.)

A key feature of the GoM model is that it allows that each sample has a proportion of membership in each cluster, rather than a discrete cluster structure. Consequently it can provide insights into how well a particular dataset really fits a "discrete cluster" model. For example, consider the results for the data from Jaitin *et al* \[[@pgen.1006599.ref032]\] and Deng *et al* \[[@pgen.1006599.ref033]\]: in both cases most samples are assigned to multiple clusters, although the results are closer to "discrete" for the latter than the former. The GoM model is also better able to represent the situation where there is not really a single clustering of the samples, but where samples may cluster differently at different genes. For example, in the GTEx data, the stomach samples share memberships in common with both the pancreas (purple) and the adrenal gland (light green). This pattern can be seen in the Structure plot ([S4 Fig](#pgen.1006599.s004){ref-type="supplementary-material"}) but not from other methods like PCA, *t*-SNE or hierarchical clustering ([Fig 2](#pgen.1006599.g002){ref-type="fig"}).

Fitting GoM models can be computationally-intensive for large data sets. For the datasets we considered here the computation time ranged from 12 minutes for the data from \[[@pgen.1006599.ref033]\] (*n* = 259;*K* = 6), through 33 minutes for the data from \[[@pgen.1006599.ref032]\] (*n* = 1,041;*K* = 7) to 3,370 minutes for the GTEx data (*n* = 8,555;*K* = 20). Computation time can be reduced by fitting the model to only the most highly expressed genes, and we often use this strategy to get quick initial results for a dataset. Because these methods are widely used for clustering very large document datasets there is considerable ongoing interest in computational speed-ups for very large datasets, with "on-line" (sequential) approaches capable of dealing with millions of documents \[[@pgen.1006599.ref049]\] that could be useful in the future for very large RNA-seq datasets.

A thorny issue that arises when fitting clustering models is how to select the number of clusters, *K*. Like many software packages for fitting these models, the `maptpx` package implements a measure of model fit that provides one useful guide. However, it is worth remembering that in practice there is unlikely to be a "true" value of *K*, and results from different values of *K* may complement one another rather than merely competing with one another. For example, seeing how the fitted model evolves as *K* increases is one way to capture some notion of hierarchy in the clusters identified \[[@pgen.1006599.ref021]\]. More generally it is often fruitful to analyse data in multiple ways using the same tool: for example our GTEx analyses illustrate how analysis of subsets of the data (in this case the brain samples) can complement analyses of the entire data. Finally, as a practical matter, we note that Structure plots can be difficult to read for large *K* (e.g. *K* = 30) because of the difficulties of choosing a palette with *K* distinguishable colors.

The version of the GoM model fitted here is relatively simple, and could certainly be embellished. For example, the model allows the expression of each gene in each cluster to be a free parameter, whereas we might expect expression of most genes to be "similar" across clusters. This is analogous to the idea in population genetics applications that allele frequencies in different populations may be similar to one another \[[@pgen.1006599.ref050]\], or in document clustering applications that most words may not differ appreciably in frequency in different topics. In population genetics applications incorporating this idea into the model, by using a correlated prior distribution on these frequencies, can help improve identification of subtle structure \[[@pgen.1006599.ref050]\] and we would expect the same to happen here for RNA-seq data.

Finally, GoM models can be viewed as one of a larger class of "matrix factorization" approaches to understanding structure in data, which also includes PCA, non-negative matrix factorization (NMF), and sparse factor analysis (SFA); see \[[@pgen.1006599.ref051]\]. This observation raises the question of whether methods like SFA might be useful for the kinds of analyses we performed here. (NMF is so closely related to the GoM model that we do not discuss it further; indeed, the GoM model is a type of NMF, because both grades of membership and expression levels within each cluster are required to be non-negative.) Informally, SFA can be thought of as a generalization of the GoM model that allows samples to have *negative* memberships in some "clusters" (actually, "factors"). This additional flexibility should allow SFA to capture certain patterns more easily than the GoM model. For example, a small subset of genes that are over-expressed in some samples and under-expressed in other samples could be captured by a single sparse factor, with positive loadings in the over-expressed samples and negative loadings in the other samples. However, this additional flexibility also comes at a cost of additional complexity in visualizing the results. For example, [S10](#pgen.1006599.s010){ref-type="supplementary-material"}, [S11](#pgen.1006599.s011){ref-type="supplementary-material"} and [S12](#pgen.1006599.s012){ref-type="supplementary-material"} Figs show results of SFA (the version from \[[@pgen.1006599.ref051]\]) for the GTEx data and the mouse preimplantation data: in our opinion, these do not have the simplicity and immediate visual appeal of the GoM model results. Also, applying SFA to RNA-seq data requires several decisions to be made that can greatly impact the results: what transformation of the data to use; what method to induce sparsity (there are many; e.g. \[[@pgen.1006599.ref051]--[@pgen.1006599.ref054]\]); whether to induce sparsity in loadings, factors, or both; etc. Nonetheless, we certainly view SFA as complementing the GoM model as a promising tool for investigating the structure of RNA-seq data, and as a promising area for further work.

Materials and methods {#sec010}
=====================

Model fitting {#sec011}
-------------

We use the `maptpx` R package \[[@pgen.1006599.ref020]\] to fit the GoM models ([1](#pgen.1006599.e001){ref-type="disp-formula"} and [2](#pgen.1006599.e002){ref-type="disp-formula"}), which is also known as "Latent Dirichlet Allocation" (LDA). The `maptpx` package fits this model using an EM algorithm to perform Maximum a posteriori (MAP) estimation of the parameters *q* and *θ*. See \[[@pgen.1006599.ref020]\] for details.

Visualizing results {#sec012}
-------------------

In addition to the Structure plot, we have also found it useful to visualize results using t-distributed Stochastic Neighbor Embedding (t-SNE), which is a method for visualizing high dimensional datasets by placing them in a two dimensional space, attempting to preserve the relative distance between nearby samples \[[@pgen.1006599.ref024], [@pgen.1006599.ref025]\]. Compared with the Structure plot our t-SNE plots contain less information, but can better emphasize clustering of samples that have similar membership proportions in many clusters. Specifically, t-SNE tends to place samples with similar membership proportions together in the two-dimensional plot, forming visual "clusters" that can be identified by eye (e.g. <http://stephenslab.github.io/count-clustering/project/src/tissues_tSNE_2.html>). This may be particularly helpful in settings where no external information is available to aid in making an informative Structure plot.

Cluster annotation {#sec013}
------------------

To help biologically interpret the clusters, we developed a method to identify which genes are most distinctively differentially expressed in each cluster. (This is analogous to identifying "ancestry informative markers" in population genetics applications \[[@pgen.1006599.ref055]\].) Specifically, for each cluster *k* we measure the distinctiveness of gene *g* with respect to any other cluster *l* using $$\text{KL}^{g}\left\lbrack k,l \right\rbrack: = \theta_{kg}\; log\frac{\theta_{kg}}{\theta_{lg}} + \theta_{lg} - \theta_{kg},$$ which is the Kullback--Leibler divergence of the Poisson distribution with parameter *θ*~*kg*~ to the Poisson distribution with parameter *θ*~*lg*~. For each cluster *k*, we then define the distinctiveness of gene *g* as $$D^{g}\left\lbrack k \right\rbrack = \min\limits_{l \neq k}\;\text{KL}^{g}\left\lbrack k,l \right\rbrack.$$ The higher *D*^*g*^\[*k*\], the larger the role of gene *g* in distinguishing cluster *k* from all other clusters. Thus, for each cluster *k* we identify the genes with highest *D*^*g*^\[*k*\] as the genes driving the cluster *k*. We annotate the biological functions of these individual genes using the `mygene` R Bioconductor package \[[@pgen.1006599.ref056]\].

For each cluster *k*, we filter out a number of genes (top 100 for the Deng *et al* data \[[@pgen.1006599.ref033]\] and GTEx V6 data \[[@pgen.1006599.ref057]\]) with highest *D*^*g*^\[*k*\] value and perform a gene set over-representation analysis of these genes against all the other genes in the data representing the background. To do this, we used ConsensusPathDB database (<http://cpdb.molgen.mpg.de/>) \[[@pgen.1006599.ref058]\] \[[@pgen.1006599.ref059]\]. See Tables [1](#pgen.1006599.t001){ref-type="table"}, [2](#pgen.1006599.t002){ref-type="table"} and [3](#pgen.1006599.t003){ref-type="table"} for the top significant gene ontologies driving each cluster in the GTEx V6 data and the Deng *et al* data respectively.

Comparison with hierarchical clustering {#sec014}
---------------------------------------

We compared the GoM model with a distance-based hierarchical clustering algorithm by applying both methods to samples from pairs of tissues from the GTEx project, and assessed their accuracy in separating samples according to tissue. For each pair of tissues we randomly selected 50 samples from the pool of all samples coming from these tissues. For the hierarchical clustering approach we cut the dendrogram at *K* = 2, and checked whether or not this cut partitions the samples into the two tissue groups. (We applied hierarchical clustering using Euclidean distance, with both complete and average linkage; results were similar and so we showed results only for complete linkage.)

For the GoM model we analysed the data with *K* = 2, and sorted the samples by their membership in cluster 1. We then partitioned the samples at the point of the steepest fall in this membership, and again we checked whether this cut partitions the samples into the two tissue groups. [S3 Fig](#pgen.1006599.s003){ref-type="supplementary-material"} shows, for each pair of tissues, whether each method successfully partitioned the samples into the two tissue groups.

Thinning {#sec015}
--------

We used "thinning" to simulate lower-coverage data from the original higher-coverage data. Specifically, if *c*~*ng*~ is the counts of number of reads mapping to gene *g* for sample *n* for the original data, we simulated thinned counts *t*~*ng*~ using $$t_{ng} \sim Bin\left( c_{ng},p_{thin} \right)$$ where *p*~*thin*~ is a specified thinning parameter.

Code availability {#sec016}
-----------------

Our methods are implemented in an R package `CountClust`, available as part of the Bioconductor project at <https://www.bioconductor.org/packages/3.3/bioc/html/CountClust.html>. The development version of the package is also available at <https://github.com/kkdey/CountClust>.

Code for reproducing results reported here is available at <http://stephenslab.github.io/count-clustering/>.

Supporting information {#sec017}
======================

###### Structure plot of GTEx V6 tissue samples for (a) *K* = 5, (b) *K* = 10, (c) *K* = 15, (d) *K* = 20.

Some tissues form a separate cluster from the other tissues from *K* = 5 onwards (for example: Whole Blood, Skin), whereas some tissue only form a distinctive subgroup at *K* = 20 (for example: Arteries).

(PDF)

###### 

Click here for additional data file.

###### Top five principal components (PC) for GTEx V6 tissue samples.

Scatter plot representation of the top five PCs of the GTEx tissue samples. Data was transformed to log2 counts per million (CPM).

(PDF)

###### 

Click here for additional data file.

###### Comparison between GoM model and hierarchical clustering under different scenarios of data transformation.

We used GTEx V6 data for model performance comparisons. Specifically, for every pair of the 53 tissues, we assessed the ability of the methods to separate samples according to their tissue of origin. The subplots of heatmaps show the results of evaluation under different scenarios. Filled squares in the heatmap indicate successful separation of the samples in corresponding tissue pair comparison. (a) Hierarchical clustering on log2 counts per million (CPM) transformed data using Euclidean distance. (b) Hierarchical clustering on the standardized log2-CPM transformed data (transformed values for each gene was mean and scale transformed) using the Euclidean distance. (c) GoM model of *K* = 2 applied to counts. (d) Hierarchical clustering on counts data with the assumption that, for each gene the sample read count *c*~*ng*~ has a variance ${\overline{c}}_{g} + 1$ that is constant across samples. And, the the gene-specific variance ${\overline{c}}_{g} + 1$ was used to scale the distance matrix for clustering. (e) Hierarchical clustering applied to adjusted count data. Each gene has a mean expression value of 0 and variance of 1. Taken together, these results suggest that regardless of the different data transformation scenarios, the GoM model with *K* = 2 is able to separate samples of different tissue of origin, better than hierarchical cluster methods.

(PDF)

###### 

Click here for additional data file.

###### GTEx brain PCA, t-SNE and MDS.

(PDF)

###### 

Click here for additional data file.

###### Structure plot of GTEx V6 tissue samples for *K* = 20 in two runs under different thinning parameter settings.

\(a\) *p*~*thin*~ = 0.01 and (B) *p*~*thin*~ = 0.0001. The structure in these two plots closely resemble the pattern observed in [Fig 1(a)](#pgen.1006599.g001){ref-type="fig"}, though there are a few differences from the unthinned version.

(PDF)

###### 

Click here for additional data file.

###### A comparison of accuracy of hierarchical clustering vs GoM on thinned GTEx data, with thinning parameters of *p*~*thin*~ = 0.01 and *p*~*thin*~ = 0.001.

For each pair of tissue samples from the GTEx V6 data we assessed whether or not each clustering method (with *K* = 2 clusters) separated the samples according to their tissue of origin, with successful separation indicated by a filled square. Thinning deteriorates accuracy compared with the unthinned data ([Fig 2](#pgen.1006599.g002){ref-type="fig"}), but even then the model-based method remains more successful than the hierarchical clustering in separating the samples by tissue or origin.

(PDF)

###### 

Click here for additional data file.

###### Deng et al (2014) PCA, tSNE, MDS and dendrogram plots for hierarchical clustering.

(PDF)

###### 

Click here for additional data file.

###### Additional GoM analysis of Deng et al (2014) data including blastocyst samples and 48 blastocyst marker genes.

We considered 48 blastocyst marker genes (as chosen by Guo et al., 2010) and fitted GoM model with *K* = 3 to 133 blastocyst samples. In the Structure plot, blastocyst samples are arranged in order of estimated membership proportion in the Green cluster. The panel located above the Structure plot shows the corresponding pre-implantation stage from which blastocyst samples were collected. The heatmap located below the Structure plot represents expression levels of the 48 blastocyst marker genes (log2 CPM), and the corresponding dendrogram shows results of hierarchical clustering (complete linkage). The table on the right of the expression heatmap displays gene information, showing, from left to right, 1) whether or not the gene is a transcription factor, 2) the driving GoM cluster if the gene was among the top five driving genes, and 3) the featured cell type (TE: trophecoderm, EPI: epiblast, PE: primitive endoderm) that was found in Guo et al., 2010.

(PDF)

###### 

Click here for additional data file.

###### Visualization of PCA and t-SNE results of mouse pre-implantation embryos data from Deng et al (2014) using 48 blastocyst marker genes.

(PDF)

###### 

Click here for additional data file.

###### Sparse Factor Analysis loadings visualization of GTEx V6 tissue samples.

The colors represent the 20 different factors. The factor loadings are presented in a stacked bar for each sample. We performed SFA under the scenarios of when the loadings are sparse (left panel) and when the factors are sparse (right panel).

(PDF)

###### 

Click here for additional data file.

###### Sparse Factor Analysis loadings visualization of GTEx brain tissue samples.

The colors represent the 6 different factors. The factor loadings are presented in a stacked bar for each sample. We performed SFA under the scenarios of when the loadings are sparse (left panel) and when the factors are sparse (right panel).

(PDF)

###### 

Click here for additional data file.

###### Sparse Factor Analysis loadings visualization of mouse pre-implantation embryos from Deng et al., (2014).

The colors represent the 6 different factors. The factor loadings are presented in a stacked bar for each sample. We performed SFA under the scenarios of when the loadings are sparse (left panel) and when the factors are sparse (right panel).
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Click here for additional data file.

###### Cluster Annotations of GTEx V6 data with top driving gene summaries.
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Click here for additional data file.

###### Cluster Annotations of GTEx V6 Brain data with top driving gene summaries.
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Click here for additional data file.

###### Cluster Annotations of Deng data with top driving genes.
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Click here for additional data file.

###### Cluster Annotation of Deng data analysis using 48 genes with top driving gene summaries.
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###### 

Click here for additional data file.
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